• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NSB 3.77% 5.5¢

NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD - News & Media

NeuroScientific Biopharmaceuticals Limited is an Australia-based company that is engaged... NeuroScientific Biopharmaceuticals Limited is an Australia-based company that is engaged in developing peptide-based pharmaceutical drugs that target a number of neurodegenerative conditions with high unmet medical demand. The Company’s product portfolio includes EmtinB, a therapeutic peptide initially targeting Alzheimer’s disease and glaucoma, as well as other Emtin peptides (EmtinAc, EmtinAn, and EmtinBn), which have demonstrated similar therapeutic potential as EmtinB. EmtinB is a peptide-based compound that binds to surface-based cell receptors from the LDLR family, activating intracellular signalling pathways that stimulate neuroprotection, neuroregeneration and modulate neuroinflammation. EmtinB is modelled on a specific active domain of the complex human protein called Metallothionein-IIA, which is produced as part of the human body’s innate immune response to cell injury. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

(20min delay)
Last
5.5¢
Change
0.002(3.77%)
Mkt cap ! $7.953M
Open High Low Value Volume
5.3¢ 5.5¢ 5.3¢ $1.035K 19.47K

Buyers (Bids)

No. Vol. Price($)
1 15688 5.2¢
 

Sellers (Offers)

Price($) Vol. No.
5.5¢ 211999 2
View Market Depth
Last trade - 16.10pm 03/05/2024 (20 minute delay) ?
Last
5.3¢
  Change
0.002 ( 3.92 %)
Open High Low Volume
5.4¢ 5.4¢ 5.3¢ 2796
Last updated 13.17pm 03/05/2024 ?
NSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.